These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6334489)

  • 21. IRT and CMT beta-lactamases and inhibitor resistance.
    Cantón R; Morosini MI; de la Maza OM; de la Pedrosa EG
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():53-62. PubMed ID: 18154528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-spectrum beta-lactamases: structure and kinetic mechanism.
    Page MG
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():63-74. PubMed ID: 18154529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isoelectric focusing of different classes of beta-lactamases in cell-free extracts of Gram-negative bacteria].
    Sazykin AIu
    Antibiot Med Biotekhnol; 1985 Jul; 30(7):495-8. PubMed ID: 3876806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers.
    Marchiaro P; Ballerini V; Spalding T; Cera G; Mussi MA; Morán-Barrio J; Vila AJ; Viale AM; Limansky AS
    J Antimicrob Chemother; 2008 Aug; 62(2):336-44. PubMed ID: 18456651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New broad-spectrum beta-lactamases].
    Fernández de Aránguiz A
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):511-3. PubMed ID: 1489789
    [No Abstract]   [Full Text] [Related]  

  • 31. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening of beta-lactamase inhibitors among representatives of the genus Micromonospora and the genus Streptoverticillium].
    Bibikova MV; Ivanitskaia LP; Nikishina VG; Rybakova AM
    Antibiotiki; 1983 Sep; 28(9):665-71. PubMed ID: 6605711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
    Kim SY; Hong SG; Moland ES; Thomson KS
    J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occurrence of extended spectrum beta-lactamases (ESBL) and inducible beta-lactamases (IBL) in clinical strains of gram-negative rods].
    Rokosz A; Sawicka-Grzelak A
    Med Dosw Mikrobiol; 1998; 50(1-2):31-9. PubMed ID: 9857611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.
    Bush K
    Clin Infect Dis; 2001 Apr; 32(7):1085-9. PubMed ID: 11264037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular characteristics of beta-lactamase from Klebsiella pneumoniae].
    Zhang Y; Li J; Zhao M
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):279-83. PubMed ID: 11953180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occurrence and susceptibility of hospital strains producing enzymes with a wide spectrum of substrate profiles].
    Góras-Zawiazalec A; Remesz A; Birawska I; Fuchs J; Ziółkowski G
    Pol Merkur Lekarski; 1997 Dec; 3(18):264-8. PubMed ID: 9523463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.